Recombinant Human FMR1 Protein，His

The FMR1 gene, located on the X chromosome, encodes the Fragile X Mental Retardation Protein (FMRP), which is crucial for neural development and synaptic plasticity. Mutations or expansions in the FMR1 gene lead to Fragile X syndrome (FXS), a common hereditary form of intellectual disability and a major cause of autism spectrum disorders. In FXS patients, the hypermethylation of the FMR1 promoter typically results in the silencing of the gene, leading to the loss of FMRP. Research on recombinant FMR1 protein focuses on understanding the structure and function of FMRP, which plays a significant role in mRNA transport and translation regulation. Through techniques such as protein expression and purification, scientists aim to investigate the molecular mechanisms underlying FMRP's role in synaptic function and neurodevelopmental processes. This research not only enhances our understanding of the pathophysiology of FXS but also opens avenues for potential therapeutic interventions targeting synaptic malfunctions associated with the absence of FMRP. By studying the FMR1 recombinant protein, researchers hope to identify critical interactions and pathways that could be modulated to restore normal function in affected individuals, thereby providing insights into strategies for treatment and management of FXS-related symptoms.